Trivium Point Advisory LLC bought a new stake in MetLife, Inc. (NYSE:MET – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 11,860 shares of the financial services provider’s stock, valued at approximately $1,003,000.
Several other large investors have also made changes to their positions in the company. Brighton Jones LLC lifted its position in MetLife by 9.0% during the 4th quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock valued at $347,000 after purchasing an additional 351 shares during the period. Caxton Associates LLP acquired a new stake in shares of MetLife during the 1st quarter worth approximately $307,000. Empowered Funds LLC grew its position in shares of MetLife by 187.6% during the 1st quarter. Empowered Funds LLC now owns 33,378 shares of the financial services provider’s stock worth $2,680,000 after buying an additional 21,771 shares during the period. Sivia Capital Partners LLC bought a new stake in shares of MetLife during the second quarter worth approximately $404,000. Finally, Jump Financial LLC bought a new stake in shares of MetLife during the second quarter worth approximately $444,000. Institutional investors and hedge funds own 94.99% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the stock. Piper Sandler raised their price objective on shares of MetLife from $86.00 to $90.00 and gave the company a “neutral” rating in a research note on Wednesday, June 24th. Keefe, Bruyette & Woods upped their target price on shares of MetLife from $105.00 to $108.00 and gave the company an “outperform” rating in a research report on Tuesday, August 11th. Mizuho raised their price target on MetLife from $95.00 to $102.00 and gave the stock an “outperform” rating in a research report on Thursday, July 9th. Jefferies Financial Group lifted their price objective on MetLife from $97.00 to $103.00 and gave the stock a “buy” rating in a research note on Friday, July 10th. Finally, Weiss Ratings upgraded MetLife from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, June 15th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $101.07.
MetLife Price Performance
MET opened at $97.57 on Monday. The stock has a market cap of $62.78 billion, a P/E ratio of 18.69, a P/E/G ratio of 0.75 and a beta of 0.78. MetLife, Inc. has a 12 month low of $67.33 and a 12 month high of $100.93. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The company has a fifty day simple moving average of $91.52 and a 200 day simple moving average of $81.58.
MetLife (NYSE:MET – Get Free Report) last posted its earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share for the quarter, topping the consensus estimate of $2.30 by $0.13. MetLife had a return on equity of 23.39% and a net margin of 4.57%.The firm had revenue of $13.52 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same period in the previous year, the company posted $2.02 earnings per share. The company’s revenue for the quarter was up 10.5% on a year-over-year basis. On average, research analysts expect that MetLife, Inc. will post 9.7 EPS for the current year.
MetLife Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Investors of record on Tuesday, August 4th will be paid a dividend of $0.5925 per share. This represents a $2.37 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, August 4th. MetLife’s dividend payout ratio is presently 45.40%.
MetLife declared that its board has authorized a stock buyback plan on Wednesday, August 5th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to buy up to 4.8% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.
About MetLife
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
Recommended Stories
- Five stocks we like better than MetLife
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
